Clinical practice guidance for juvenile dermatomyositis (JDM) 2018-Update ()

被引：6
|
作者：
Kobayashi, Ichiro
Akioka, Shinji
Kobayashi, Norimoto
Iwata, Naomi
Takezaki, Shunichiro
Nakaseko, Haruna
Sato, Satoshi
Nishida, Yutaka
Nozawa, Tomo
Yamasaki, Yuichi
Yamazaki, Kazuko
Arai, Satoru
Nishino, Ichizo
Mori, Masaaki
机构：
[1] Center for Pediatric Allergy and Rheumatology, KKR Sapporo Medical Center, Sapporo
[2] Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto
[3] Department of Pediatrics, Shinshu University School of Medicine, Matsumoto
[4] Department of Infection and Immunology, Aichi Children’s Health and Medical Center, Obu
[5] Department of Pediatrics, Hokkaido University Hospital, Sapporo
[6] Division of Infectious Disease and Immunology, Saitama Children’s Medical Center, Omiya
[7] Department of Pediatrics, School of Medicine, Gunma University, Maebashi
[8] Department of Pediatrics, School of Medicine, Yokohama City University, Yokohama
[9] Department of Pediatrics, Kagoshima University Hospital, Kagoshima
[10] Department of Pediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe
[11] Department of Dermatology, St. Luke’s International Hospital, Tokyo
[12] Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo
[13] Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo
来源：
MODERN RHEUMATOLOGY | 2020年 / 30卷 / 03期
关键词：
Diagnosis; interstitial lung disease; management; myositis-specific autoantibodies; pathophysiology;
D O I：
10.1080/14397595.2020.1764723
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Juvenile dermatomyositis is the most common type of juvenile idiopathic inflammatory myopathy mainly affecting the skin and proximal muscles. We have published the Japanese version of ‘Clinical practice guidance for juvenile dermatomyositis (JDM) 2018 ‘consisting of a review of articles in the field and evidence-informed consensus-based experts’ opinion on the treatment strategy in collaboration with The Pediatric Rheumatology Association of Japan and The Japan College of Rheumatology under the financial support by ‘Research on rare and intractable diseases, Health and Labor Sciences Research Grants’. This article is a digest version of the Japanese guidance. © 2019, © 2019 Japan College of Rheumatology. Published by Informa UK Limited, trading as Taylor & Francis Group.
引用
收藏
页码：607 / 607
页数：1
相关论文
共 50 条
  • [41] Scrotum and testicular calcinosis in juvenile dermatomyositis (JDM). A report of two cases
    Sallum, A. M. E.
    Garcia, A. J. M.
    Saito, O. C.
    Silva, C. A. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : 382 - 383
  • [42] Validation of manual muscle testing (MMT) in the assessment of juvenile dermatomyositis (JDM).
    Hicks, J
    Wesley, R
    Koziol, D
    Smith, M
    Jain, M
    Cintas, H
    Lovell, D
    Feldman, B
    Bowyer, S
    Ballinger, S
    Lindsley, C
    Pachman, L
    Miller, F
    Rider, L
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S194 - S194
  • [43] Muscle biopsy (MBx) evaluation in juvenile dermatomyositis (JDM): Evidence of recanalization
    Pachman, LM
    Lingen, M
    Mendez, E
    Chen, EH
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 654 - 654
  • [44] Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM)
    Abdul-Aziz, Rabheh
    Yu, Chack-Yung
    Adler, Brent
    Bout-Tabaku, Sharon
    Lintner, Katherine E.
    Moore-Clingenpeel, Melissa
    Spencer, Charles H.
    PEDIATRIC RHEUMATOLOGY, 2017, 15
  • [45] Lung involvement in juvenile dermatomyositis (JDM): Muscle strength and pulmonary function tests in children with JDM.
    Trapani, S
    Camiciottoli, G
    Ermini, M
    Lavorini, F
    Falcini, F
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S266 - S266
  • [46] OXIDISED MITOCHONDRIAL DNA: A NEW THERAPEUTIC TARGET IN JUVENILE DERMATOMYOSITIS (JDM)
    Wilkinson, Meredyth G. L. L.
    Moulding, Dale
    McDonnell, Thomas C. R.
    Orford, Mi-Chael
    Wincup, Chris
    Ting, Joanna
    Otto, Georg
    Kelberman, Daniel
    Castellano, Sergi
    Eaton, Simon
    Deakin, Claire T.
    Rosser, Elizabeth C.
    Wedderburn, Lucy R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 431 - 431
  • [47] Experience with etanercept in chronic juvenile dermatomyositis (JDM): Preliminary results.
    Miller, ML
    Mendez, E
    Klein-Gitelman, MS
    Pachman, LM
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S380 - S380
  • [48] Familial Clustering of Dysbiotic Oral and Fecal Microbiomes in Juvenile Dermatomyositis (JDM)
    Chow, Albert
    Koester, Sean
    Pepper-Tunick, Evan
    Lee, Peggy
    Eckert, Mary
    Brenchley, Laurie
    Gardner, Pamela
    Li, Naisi
    Schiffenbauer, Adam
    Volochayev, Rita
    Bayat, Nastaran
    McLean, Jeffrey
    Rider, Lisa
    Shenoi, Susan
    Stevens, Anne
    Dey, Neelendu
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2385 - 2387
  • [49] Cytokine and HLA alleles modulate disease severity in juvenile dermatomyositis (JDM).
    Mamyrova, G.
    Sillers, L.
    O'Hanlon, T.
    Pandey, J.
    Malley, J.
    Adams, S.
    James-Newton, L.
    Wallace, C.
    Sherry, D.
    Imundo, L.
    Lindsley, C.
    Madson, K.
    Perez, M.
    Miller, F.
    Rider, L.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S692 - S692
  • [50] Juvenile Dermatomyositis as a Paraneoplastic Phenomenon: An Update
    Morris, Paula
    Dare, Jason
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (03) : 189 - 191
12345